Skip to content

Clinical trials

Sarcoma, Kaposi trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma, Kaposi Clear all

154 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20016
20023
20034
20041
20053
20063
20073
20084
20091
20106
20113
20122
20131
20144
20153
20163
20174
20184
20205
20218
20221
20236
20245
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed102
Recruiting19
Terminated13
Unknown status7
Active, not recruiting6
Withdrawn4
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)35
National Institute of Allergy and Infectious Diseases (NIAID)17
AIDS Malignancy Consortium13
Alpha Tau Medical LTD.5
Daiichi Pharmaceuticals4
Memorial Sloan Kettering Cancer Center4
Sequus Pharmaceuticals4
University of California, San Francisco4
Washington University School of Medicine4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma, Kaposi154
Acquired Immunodeficiency Syndrome61
HIV Infections61
Sarcoma32
Neoplasms18
Skin Neoplasms16
Lymphoma, Non-Hodgkin13
Squamous Cell Carcinoma of Head and Neck12
Lymphoma11
Osteosarcoma11

Trials

Showing 76 to 100 of 154. Each trial links to its page on Pharma Observatory.

54 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.